Minimizing out-of-pocket health expenditure for India's poor

India allocates just 0.1 percent of GDP on publicly funded drugs and medicines — a catastrophe for the country's vast poor population, argues Sachi Satapathy, a technical officer at The International Union Against Tuberculosis and Lung Disease, in this guest column.

The views in this opinion piece do not necessarily reflect Devex's editorial views.

About the author

  • Sachi Satapathy

    Sachi Satapathy is an international development practitioner specialized in program management, policy development, strategic communications and advocacy and worked on large scale projects with bilateral and multilateral agencies. His interests are in public health, poverty alleviation and in public-private partnerships for health and development in lower, middle income and developing countries.